Drotrecogin Alfa (activated, Xigris®) in Combination with Heparin or Melagatran: An In vitro Investigation Martin KoestenbergerGerhard CvirnWolfgang Muntean OriginalPaper Pages: 5 - 10
GPIIb/IIIa Inhibitor-Induced Dethrombosis Mark I. FurmanA. L. FrelingerAlan D. Michelson OriginalPaper Pages: 11 - 17
The Effect of Temperature Variation In Vitro on Platelet-Leukocyte Interactions and Individual Prothrombotic Potential Youfu LiKristian C.D. BeckerRichard C. Becker OriginalPaper Pages: 19 - 23
Does Clopidogrel Increase the Degree of Platelet Inhibition When a Platelet Glycoprotein IIb/IIIa Inhibitor Has Been Given? Insights From an Optical Platelet Aggregometry Study Deepak TalrejaDieter LubbePeter B. Berger OriginalPaper Pages: 25 - 30
Argatroban Anticoagulation in Conjunction with Glycoprotein IIb/IIIa Inhibition in Patients Undergoing Percutaneous Coronary Intervention: An Open-Label, Nonrandomized Pilot Study Ik-Kyung JangBruce E. LewisNeal S. Kleiman OriginalPaper Pages: 31 - 37
Statin Reduce the Platelet P-Selectin Expression in Atherosclerotic Ischemic Stroke Jae-Kwan ChaMin-Ho JeongJae Woo Kim OriginalPaper Pages: 39 - 42
Fibrinolysis of Acute Peripheral Arterial Occlusion with Tenecteplase—A New Weight-Optimized Treatment Regimen Christoph MelzerChristoph RichterMichael Laule OriginalPaper Pages: 43 - 46
Tenecteplase for the Treatment of Massive and Submassive Pulmonary Embolism Christoph MelzerChristoph RichterMichael Laule OriginalPaper Pages: 47 - 50
Some Considerations About the Composition, in vivo Detection and Therapeutic Approaches to the Coronary Atherosclerotic Plaques in Diabetes Mellitus Federico Cacciapuoti OriginalPaper Pages: 51 - 53
Optimizing Heparin Compounds: A Working Construct for Future Antithrombotic Drug Development Richard C. Becker OriginalPaper Pages: 55 - 58